Navigation Links
Tamoxifen trial should prompt breast cancer patients to reconsider treatment options
Date:12/6/2012

MAYWOOD, Il. - A groundbreaking clinical trial involving the breast cancer drug tamoxifen should prompt certain breast cancer patients to reconsider their treatment options, according to Loyola University Medical Center breast cancer specialist Dr. Kathy Albain.

The trial is called ATLAS (Adjuvant Tamoxifen Longer Against Shorter). It included women with estrogen receptor-positive breast cancer that had not spread to distant organs. Women who took tamoxifen for 10 years had a lower risk of recurrence and lower mortality rate than women who took the drug for 5 years, which is the current standard of care.

"I think this is going to create a need for women with this type of breast cancer to readdress their treatment options," Albain said.

Dr. Richard Gray, on behalf of the ATLAS trial investigators, announced results Dec. 5 during the San Antonio Breast Cancer Symposium. Albain moderated the opening oral session in which the results were announced and discussed.

A worldwide team of investigators enrolled 6,846 women with estrogen receptor-positive breast cancer who had been taking tamoxifen for five years and were free of recurrence of their breast cancer. Women were randomly assigned to either stop taking tamoxifen, or to continue taking the drug for another five years.

During the second decade following diagnosis, women who continued taking tamoxifen had a 25 percent lower recurrence rate and a 29 percent lower breast cancer mortality rate, compared with women who stopped after five years. Overall, taking tamoxifen for 10 years cut the risk of dying of breast cancer in half.

Albain noted there are risks to taking tamoxifen, including a higher risk of endometrial cancer in postmenopausal patients and an increased risk of blood clots. But endometrial cancer generally is curable, and in certain women, the benefits of taking tamoxifen for longer periods may outweigh the risks, Albain said.

Premenopausal
'/>"/>

Contact: Jim Ritter
jritter@lumc.edu
708-216-2445
Loyola University Health System
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Possible therapy for tamoxifen resistant breast cancer identified
2. New finding gives clues for overcoming tamoxifen-resistant breast cancer
3. 10 Years of Tamoxifen Better Than 5: Study
4. Brain Tumor Vaccine Shows Promise in Early Trial
5. URMC clinical trial tests new regimen for hypertension
6. Analysis Finds Clinical Trials Often Small, of Poor Quality
7. US spends far more for health care than 12 industrialized nations, but quality varies
8. New Weight-Loss Drug Shows Promise in Trial
9. Palpitations are predictive of future atrial fibrillation
10. Trial Set to See if Drug Can Prevent Alzheimers
11. Experts call for clinical trials to test non-skeletal benefits of vitamin D
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... CA (PRWEB) May 05, 2015 Nutritional ... and actually prevent a variety of health conditions and ... this modern research to adopt clean eating methods to ... artificial dyes associated with over-consumption of fast and processed ... plans easy to follow and report feeling better ...
(Date:5/5/2015)... MAP Health Management, LLC, a provider of ... addiction treatment facilities, announced today that Jimmy Mooney has ... Mr. Mooney, who has more than 35 years of ... for developing new strategic partnerships with substance abuse facilities ... new initiatives. , Prior to joining MAP, Mr. Mooney ...
(Date:5/5/2015)... Washington, DC (PRWEB) May 05, 2015 ... Amplify Hope Initiative, a new study aimed at determining ... disease patients. RG is an international non-profit providing rare ... genomics sequencing technology, connections to scientists and researchers, and ... or crowdfunding. , “I am excited to see how ...
(Date:5/5/2015)... May 05, 2015 For the growing list ... series of data loggers. This data logger series ... electronic components for optimum performance throughout exposure to high temperatures ... loggers are capable of storing up to 32,700 readings ... life of one year or longer. All data loggers in ...
(Date:5/5/2015)... 2015 Sheltering Arms held its annual ... Frazier and Cravath, Swaine & Moore LLP for their ... The event was co-chaired by Vanguard sponsors Morgan Stanley ... Chapter” highlighted Sheltering Arms’ significant growth in New York ... February 2015. Formerly Episcopal Social Services, Sheltering Arms has ...
Breaking Medicine News(10 mins):Health News:Diet Doc Introduces Diet Plans that Teach Patients how to Eat Clean by Getting Back to Basics and Exchanging Processed Foods for Clean, Nutritious Foods 2Health News:Diet Doc Introduces Diet Plans that Teach Patients how to Eat Clean by Getting Back to Basics and Exchanging Processed Foods for Clean, Nutritious Foods 3Health News:Jimmy Mooney, an Addiction Treatment Veteran, Named Vice President of Business Development at MAP Health Management, LLC 2Health News:Rare Genomics Institute to Study Impact of Crowdfunding on Rare Diseases 2Health News:MadgeTech High Temperature Data Logger Series Expands for Growing Demands 2Health News:MadgeTech High Temperature Data Logger Series Expands for Growing Demands 3Health News:MadgeTech High Temperature Data Logger Series Expands for Growing Demands 4Health News:MadgeTech High Temperature Data Logger Series Expands for Growing Demands 5Health News:MadgeTech High Temperature Data Logger Series Expands for Growing Demands 6Health News:Sheltering Arms Honors Walt "Clyde" Frazier and Cravath, Swaine & Moore LLP at Annual Gala 2
... Hanger Orthopedic,Group, Inc. (NYSE: HGR ) announces ... 30, 2008, an increase of $16.4 million, or 10.1%,from ... income for,the quarter was $7.3 million, an increase of ... year. Diluted earnings per share for the,third quarter 2008 ...
... later, studies find , , MONDAY, Oct. 27 (HealthDay News) ... the risk of a heart attack, and those who ... heart-related complications, new research says. , It seems ... lower chambers of the heart to become stiff, is ...
... the growing number who choose later-in-life pregnancy, predicting their ... and infertility is critically important. , Now, investigators ... about hormonal biomarkers that can address the beginning ... this information can change the way we do business," ...
... The HealthCentral,Network, Inc. (http://www.HealthCentral.com ) announced today ... for HealthCentral, has been,named President and Chief Operating ... track record of growing young businesses, Shane will,oversee ... for,audience growth, user engagement, and revenue, and will ...
... Web-based project educates and empowers through personal stories of,North ... N.C., Oct. 27 Eighty percent of,women living with ... leading cause of death for African American women ages ... and Test for Life,will host a demonstration and discussion ...
... AARP, one of the world,s,largest member organizations with ... people 50+, today announced that renown journalist and ... been named Ambassador,of Caregiving for the organization. In ... members through the emotional and practical sides of,the ...
Cached Medicine News:Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 2Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 3Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 4Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 5Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 6Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 7Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 8Health News:Hanger Orthopedic Group, Inc. Exceeds Estimates on a 10% Sales Increase and a 28% EPS Increase to $0.23 for the Third Quarter 2008 9Health News:Rheumatoid Arthritis a Threat to the Heart 2Health News:Rheumatoid Arthritis a Threat to the Heart 3Health News:Rheumatoid Arthritis a Threat to the Heart 4Health News:New hormone data can predict menopause within a year 2Health News:The HealthCentral Network Names Jeremy Shane President and Chief Operating Officer 2Health News:The HealthCentral Network Names Jeremy Shane President and Chief Operating Officer 3Health News:Southern AIDS Living Quilt Project in Raleigh Tomorrow 2Health News:Gail Sheehy Named AARP's Ambassador of Caregiving 2Health News:Gail Sheehy Named AARP's Ambassador of Caregiving 3
(Date:5/5/2015)... -- ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP ) today ... 31, 2015 and reaffirmed its revenue, non-GAAP EBITDA, and ... First Quarter 2015 Highlights Include: , First quarter ... compared to $10.9 million for the same period in ... $11.5 million, an increase of 170% as compared to $4.2 ...
(Date:5/5/2015)...  InfuSystem Holdings, Inc. (NYSE MKT: INFU), a leading ... the U.S. healthcare industry, today announced that it will ... 2015 after the market closes. The Company ... Tuesday, May 12, 2015 at 4:30 p.m. Eastern Time ... in this call, please dial in toll-free 1-800-446-1671 and ...
(Date:5/5/2015)... 5, 2015 The National Association of ... of its 6 th Annual Most Influential ... CEO of Ear Professionals International Corporation (dba EPIC ... in the nation, EPIC Hearing Service Plans cover ... care organizations, employers, health plans, unions and through ...
Breaking Medicine Technology:ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 2ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 3ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 4ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 5ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 6ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 7ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 8ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 9EPIC Hearing Healthcare CEO Brad Volkmer Awarded 6th Annual Most Influential In Specialty Health 2
... Oct. 5, 2011 In an independent study published ... University of Texas Health Science Center San Antonio have ... compromised blood flow during reconstructive microsurgery when compared clinically ... by Dr. Cornejo and colleagues is important as compromised ...
... "Superheroes of Nursing" shows appreciation to nurses; contest ... four-month period Elsevier , a world-leading ... services, announced today the winners of the Mosby,s Nursing ... to search and identify the real-life superheroes in the ...
Cached Medicine Technology:Spectros T-Stat Shown to Be Earliest Available Method for Detection of Surgical Skin Flap Compromise After Surgery 2Real Superheroes of Nursing, from Mosby's Nursing, Announced at 13th Annual ANCC Magnet Conference 2Real Superheroes of Nursing, from Mosby's Nursing, Announced at 13th Annual ANCC Magnet Conference 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: